Tema Neuroscience and Mental Health ETF
MNTL
MNTL was delisted on the 6th of August, 2025.
3 hedge funds and large institutions have $956K invested in Tema Neuroscience and Mental Health ETF in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
16% more capital invested
Capital invested by funds: $820K → $956K (+$135K)
0.98% more ownership
Funds ownership: 7.25% → 8.23% (+0.98%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
25% less funds holding
Funds holding: 4 → 3 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$118K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$2.39K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$427 |
MNTL Hedge Fund Activity: Q3 2024 in Review
3 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Tema Neuroscience and Mental Health ETF (MNTL) for Q3 2024, worth a combined $956K — up 16% from $820K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of MNTL and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Old Mission Capital, adding an estimated $118K. The largest seller was UBS Group, exiting entirely with an estimated $2.39K sold.
- 3 institutional investors held Tema Neuroscience and Mental Health ETF (MNTL) as of Q3 2024, down from 4 in Q2 2024.
- Funds reported $956K of Tema Neuroscience and Mental Health ETF stock for Q3 2024, up 16% quarter-over-quarter.
- 0 funds opened new Tema Neuroscience and Mental Health ETF positions in Q3 2024 and 1 closed out, a net change of -1 holder.
- The largest Tema Neuroscience and Mental Health ETF buyer in Q3 2024 was Old Mission Capital, an estimated $118K added.
- The largest Tema Neuroscience and Mental Health ETF seller in Q3 2024 was UBS Group, an estimated $2.39K sold.
Based on aggregated 13F filings for Q3 2024.